V015-6595 Screening compound: 4-butyl-N-[2-({2-[(3,5-dimethylphenoxy)methyl]-1,3-thiazol-4-yl}formamido)ethyl]benzamide

V015-6595 Screening compound: 4-butyl-N-[2-({2-[(3,5-dimethylphenoxy)methyl]-1,3-thiazol-4-yl}formamido)ethyl]benzamide
V015-6595 Screening compound: 4-butyl-N-[2-({2-[(3,5-dimethylphenoxy)methyl]-1,3-thiazol-4-yl}formamido)ethyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-6595
4-butyl-N-[2-({2-[(3,5-dimethylphenoxy)methyl]-1,3-thiazol-4-yl}formamido)ethyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-6595

Molecular Formula

C26H31N3O3S (C26 H31 N3 O3 S)

Compound Name

4-butyl-N-[2-({2-[(3,5-dimethylphenoxy)methyl]-1,3-thiazol-4-yl}formamido)ethyl]benzamide

IUPAC name

4-butyl-N-[2-({2-[(35-dimethylphenoxy)methyl]-13-thiazol-4-yl}formamido)ethyl]benzamide

SMILES

CCCCc(cc1)ccc1C(NCCNC(c1csc(COc2cc(C)cc(C)c2)n1)=O)=O

InChI

InChI=1S/C26H31N3O3S/c1-4-5-6-20-7-9-21(10-8-20)25(30)27-11-12-28-26(31)23-17-33-24(29-23)16-32-22-14-18(2)13-19(3)15-22/h7-10,13-15,17H,4-6,11-12,16H2,1-3H3,(H,27,30)(H,28,31)

InChI Key

OILOQBWEOXOKBG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19968045

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

465.62

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.524

Distribution Coefficient, logD

5.524

Water Solubility, LogSw

-5.27

Polar Surface Area

66.748

Acid Dissociation Constant (pKa)

13.64

Base Dissociation Constant (pKb)

-3.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

V015-6595 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V015-6595 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-6595?
Check Price and Availability of V015-6595, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-6595 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-6595
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-6595
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-6595 available by request